Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Enterprise value to EBITDA ratio
3Y CAGR
-24.9%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 32.12 | +213.9% |
| 2024 | -28.21 | +43.1% |
| 2023 | -49.58 | -165.4% |
| 2022 | 75.77 | +1792.5% |
| 2021 | -4.48 | +30.8% |
| 2020 | -6.47 | -87.7% |
| 2019 | -3.45 | +28.9% |
| 2018 | -4.85 | +46.0% |
| 2017 | -8.97 | +62.7% |
| 2016 | -24.03 | - |